Nehal S. Parikh

1.5k total citations
21 papers, 987 citations indexed

About

Nehal S. Parikh is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Nehal S. Parikh has authored 21 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Nehal S. Parikh's work include Cancer, Hypoxia, and Metabolism (5 papers), Neuroblastoma Research and Treatments (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Nehal S. Parikh is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Neuroblastoma Research and Treatments (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Nehal S. Parikh collaborates with scholars based in United States, South Korea and Argentina. Nehal S. Parikh's co-authors include Krishnan Venkataraman, Timothy Hla, Youxi Ai, Yong-Moon Lee, Shobha Thangada, Jason Michaud, Herbert L. Bonkovsky, Héctor L. Aguila, Frank S. Lee and Xiping Li and has published in prestigious journals such as Blood, Circulation Research and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Nehal S. Parikh

19 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nehal S. Parikh United States	10	690	231	205	163	117	21	987
Shailaja Akunuru United States	14	528 0.8×	125 0.5×	144 0.7×	82 0.5×	78 0.7×	14	900
Daniel S. Pearson United States	9	623 0.9×	345 1.5×	135 0.7×	181 1.1×	92 0.8×	16	920
Ian D. Tonks Australia	17	929 1.3×	169 0.7×	227 1.1×	63 0.4×	173 1.5×	26	1.3k
Angela Russo United States	20	537 0.8×	141 0.6×	141 0.7×	62 0.4×	83 0.7×	38	1.0k
Ruoqian Shen United States	18	593 0.9×	283 1.2×	110 0.5×	63 0.4×	131 1.1×	27	1.2k
Li‐Juan Duan United States	13	524 0.8×	610 2.6×	72 0.4×	151 0.9×	213 1.8×	28	943
Anu Gupta United States	16	555 0.8×	133 0.6×	81 0.4×	43 0.3×	77 0.7×	22	954
Huifei Liu United States	12	807 1.2×	176 0.8×	77 0.4×	83 0.5×	135 1.2×	29	1.2k
Scott A. Coats United States	10	428 0.6×	206 0.9×	78 0.4×	88 0.5×	143 1.2×	11	956
Xinchun Pi United States	15	578 0.8×	179 0.8×	105 0.5×	96 0.6×	46 0.4×	18	818

Countries citing papers authored by Nehal S. Parikh

Since Specialization

Citations

This map shows the geographic impact of Nehal S. Parikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nehal S. Parikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nehal S. Parikh more than expected).

Fields of papers citing papers by Nehal S. Parikh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nehal S. Parikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nehal S. Parikh. The network helps show where Nehal S. Parikh may publish in the future.

Co-authorship network of co-authors of Nehal S. Parikh

This figure shows the co-authorship network connecting the top 25 collaborators of Nehal S. Parikh. A scholar is included among the top collaborators of Nehal S. Parikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nehal S. Parikh. Nehal S. Parikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parikh, Nehal S., et al.. (2025). Tumor Lysis Syndrome in Metastatic Prostate Cancer. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3960–A3960.

Curigliano, Giuseppe, M.M. Jimenez, Tomokazu Shimizu, et al.. (2024). A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies. ESMO Open. 9(8). 103643–103643. 7 indexed citations

Bhola, Neil E., Yuping Chen, Kevin X. Chen, et al.. (2023). Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor. Cancer Research Communications. 3(9). 1731–1742. 2 indexed citations

Matthay, Katherine K., Mohammed Khattab, Shui Yen Soh, et al.. (2022). Global Neuroblastoma Network: An international multidisciplinary neuroblastoma tumor board for resource‐limited countries. Pediatric Blood & Cancer. 69(4). e29568–e29568. 6 indexed citations

DiNardo, Courtney D., Andreas Hochhaus, Mark G. Frattini, et al.. (2022). A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome. Journal of Cancer Research and Clinical Oncology. 149(3). 1145–1158. 22 indexed citations

Curigliano, Giuseppe, M. Martín Jiménez, Toshio Shimizu, et al.. (2021). Abstract CT103: Phase I study of LHC165 ± spartalizumab (PDR001) in patients (pts) with advanced solid tumors. Cancer Research. 81(13_Supplement). CT103–CT103. 9 indexed citations

Conlon, Kevin C., Rom S. Leidner, Douglas G. McNeel, et al.. (2019). Abstract CT082: Phase (Ph) I/Ib study of NIZ985 with and without spartalizumab (PDR001) in patients (pts) with metastatic/unresectable solid tumors. Cancer Research. 79(13_Supplement). CT082–CT082. 2 indexed citations

Conlon, Kevin C., Rom S. Leidner, Douglas G. McNeel, et al.. (2019). Abstract CT082: Phase (Ph) I/Ib study of NIZ985 with and without spartalizumab (PDR001) in patients (pts) with metastatic/unresectable solid tumors. Clinical Trials. CT082–CT082. 1 indexed citations

Deane, Jonathan A., Chun Li, Shailaja Kasibhatla, et al.. (2019). Abstract 4128: Identification and characterization of LHC165, a TLR7 agonist designed for localized intratumoral therapies. Cancer Research. 79(13_Supplement). 4128–4128. 9 indexed citations

10.

Parikh, Nehal S., Scott C. Howard, Guillermo Chantada, et al.. (2015). SIOP‐PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low‐ and middle‐income settings. Pediatric Blood & Cancer. 62(8). 1305–1316. 71 indexed citations

11.

Mnayer, Laila, et al.. (2015). A Case Report. Journal of Pediatric Hematology/Oncology. 37(7). e429–e432. 6 indexed citations

12.

Jensen, Todd, et al.. (2015). Descriptive analysis of tumor cells with stem like phenotypes in metastatic and benign adrenal tumors. Journal of Pediatric Surgery. 50(9). 1493–1501. 10 indexed citations

13.

Sholler, Giselle L. Saulnier, Eugene W. Gerner, Genevieve Bergendahl, et al.. (2013). Abstract LB-179: Phase I trial of relapsed neuroblastoma with DFMO alone and in combination with etoposide.. Cancer Research. 73(8_Supplement). LB–179. 2 indexed citations

14.

Sholler, Giselle L. Saulnier, William S. Ferguson, Genevieve Bergendahl, et al.. (2012). A Pilot Trial Testing the Feasibility of Using Molecular-Guided Therapy in Patients with Recurrent Neuroblastoma. Journal of Cancer Therapy. 3(5). 602–612. 12 indexed citations

15.

Scarpato, Kristen R., et al.. (2011). Primary renal synovial sarcoma in a 13-year-old boy. Journal of Pediatric Surgery. 46(9). 1849–1851. 4 indexed citations

16.

Venkataraman, Krishnan, Yong-Moon Lee, Jason Michaud, et al.. (2008). Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate. Circulation Research. 102(6). 669–676. 391 indexed citations

17.

Takeda, Kotaro, Héctor L. Aguila, Nehal S. Parikh, et al.. (2007). Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood. 111(6). 3229–3235. 223 indexed citations

18.

Venkataraman, Krishnan, Shobha Thangada, Jason Michaud, et al.. (2006). Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochemical Journal. 397(3). 461–471. 173 indexed citations

19.

Parikh, Nehal S., Mark A. Currier, Yonatan Y. Mahller, et al.. (2004). Oncolytic herpes simplex virus mutants are more efficacious than wild‐type adenovirus Type 5 for the treatment of high‐risk neuroblastomas in preclinical models. Pediatric Blood & Cancer. 44(5). 469–478. 34 indexed citations

20.

Parikh, Nehal S., James D. Hoyer, & Timothy P. Cripe. (2004). A young girl with hemolytic anemia and elevated hemoglobin F. Pediatric Blood & Cancer. 44(3). 264–266. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact